Image showing pills and a magnifying glass
Safety committee meeting: May 2025 highlights

New recommendations on finasteride and Ixchiq vaccine

Read highlights
Finasteride referral
New safety recommendations on finasteride and dutasteride

Measures minimise risk of suicidal thoughts

Read public health communication
NDSG workplan
Leveraging large volumes of data and new tools for public and animal health

EU regulators agree workplan to optimise use of data and AI

Explore workplan
Ixchiq chikungunya vaccine
Safety review of chikungunya vaccine Ixchiq started

Vaccine must not be used in people 65 years and above

Read statement on chikungunya
Magnified biosimilar medicine
Streamlining development and assessment of biosimilar medicines

Public consultation open until end September 2025

Send your comments
Network strategy to 2028
EU medicines agencies’ network strategy to 2028

Seizing opportunities in a changing medicines landscape

Read strategy
Icon Magnify Glass

Find medicine

Find information on centrally authorised medicines
Icon Megaphone

What's new

Find all new and updated information published on our website in one place
icon speech question answer

FAQs

Find answers to the most frequent asked questions we receive

Latest news

EMA closed on 9 May

The European Medicines Agency's (EMA) office is closed from 18:00 on 8 May 2025 to 08:30 on 12 May 2025

7 May 2025
SEE ALL NEWS

Events

EMA Open Door Day
European Medicines Agency, Amsterdam, the Netherlands
Start date: 9 May 2025, 09:45 (CEST)
End date: 9 May 2025, 16:00 (CEST)
SEE ALL EVENTS
EMA Custom Webtools Rating widget: Hidden by field_ema_hide_rating for this node.
Back to top